Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency

  • Tara Hurst
  • , Matthew Pace
  • , Aris Katzourakis
  • , Rodney Phillips
  • , Paul Klenerman
  • , John Frater*
  • , Gkikas Magiorkinis
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    28 Citations (SciVal)
    Original languageEnglish
    Article number10
    JournalRetrovirology
    Volume13
    Issue number1
    DOIs
    Publication statusPublished (VoR) - 6 Feb 2016

    Funding

    TH and GM are supported by an MRC Clinician Scientist Fellowship awarded to GM. AK is supported by a Royal Society University Research Fellowship. JF is supported by a MRC Senior Clinical Fellowship, the Oxford Martin School and the Oxford NIHR Comprehensive Biomedical Research Centre.

    Keywords

    • Endogenous retroviruses
    • HDAC inhibitors
    • HERV-K (HML-2)
    • HIV-1 cure
    • HIV-1 latency

    Fingerprint

    Dive into the research topics of 'Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency'. Together they form a unique fingerprint.

    Cite this